LGVN - Longeveron Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Longeveron Inc. (LGVN) specializes in cellular rejuvenation, utilizing its proprietary Lomecel-B to combat age-related fragility and dementia. The market value dynamics of the asset with the 0.00 indicator reflect the company's current positioning. The R&D center is currently focused on completing Phase II trials for Alzheimer's disease treatments. However, the business faces intense competition for investment and the risk of being displaced by more advanced gene modification methods.

LGVN Longeveron Corp: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization in the range 11/23/2025 - 11/12/2026

longeveron.com - analytical breakdowns and key metrics (LGVN)

- market price and analyst price targets:

Price Chart Longeveron Corp|LGVN - Price Target Chart

- market capitalization statistics:

Market Value Longeveron Corporation|LGVN - Company Buyout Price

- book value of equity indicators:

Net Assets per Single Share Longeveron|LGVN - Company Book Value|Market Value to Book Value Ratio longeveron.com|LGVN - Company Assets

- company liabilities and liquidity data:

- business earnings and investment ratios data:

LGVN - Company Net Income|Expected Profit Longeveron Inc.|LGVN - Company Value to Net Income|Future Price to Earnings Longeveron Inc.|LGVN - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Longeveron Corporation|LGVN - Operating profit before amortization|Net earnings per share for the last 12 months Longeveron|LGVN - Earnings per share for the trailing year|Quarterly EPS earnings growth longeveron.com|LGVN - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Longeveron Inc.

Basic company analysis:Longeveron Corp LGVN

This indicator compares the total value of assets and debt obligations against operating profit before depreciation and amortization, allowing for an assessment of the business's real value without the influence of the tax burden. By analyzing the EV/EBITDA ratio in light of operating profit and depreciation, an investor determines the financial stability of Longeveron Inc. (LGVN) during the implementation of costly robotic systems and the automation of laboratory complexes for precision reagent dosing.

Competitor analysis

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Mesoblast Corp MESO|Lineage Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRZN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Cryo-Cell International CCEL|fibrobiologics.com (FBLG) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BRTX (BioRestorative Therapies, Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Creative Medical Technology Holdings, Inc.